GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Umax Group UMAX · USD

Consumer Discretionary · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2018

Revenue

$3,970

FY2017FY2018

Net income

−$318,876

FY2017FY2018

Free cash flow

−$321,347

FY2017FY2018

Shareholders' equity

−$71,255

FY2017FY2018

Income statement

Fiscal years

FY2018FY2017
Revenue$3,970$2,225
Gross profit$3,970$2,225
Operating income−$90,943−$97,517
Net income−$318,876−$97,517

Balance sheet

At each fiscal year end

FY2018FY2017
Total assets$21,385$279,580
Total liabilities$92,640$74,639
Debt$92,640$74,640
Shareholders' equity−$71,255$204,941

Cash flow

Fiscal years

FY2018FY2017
Cash from operations−$316,877−$114,517
Capital spending−$4,470−$1,412
Free cash flow−$321,347−$115,929

Latest quarters

By quarter end

Jul 2023Oct 2013Jul 2013Apr 2013Jan 2013
Revenue$3,937$6,099$7,400——
Gross profit$3,937$5,250$1,766——
Operating income−$55,510−$79,865−$19,539−$3,314−$17,607
Net income−$58,981−$79,865−$19,539−$3,386−$17,607
Diluted earnings per share-0.00-1,996.74-488.49-172.49-440.25
Total assets$1.4m$149,337$10,778—$2,011
Debt$200,000$44,100$24,100$19,894$18,319
Shareholders' equity−$1.5m$102,007−$18,189−$19,894−$16,508

Growth per year

Compound annual rate

3 years5 years10 years
Operating income126.9%——
Net income238.5%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return100%1378578%2758%31907%-70%1848851%1526188%3663%-77%308%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 125-to-1 reverse split · 11 Sept 2018
  • 20000-to-1 reverse split · 20 Sept 2016
  • 40-for-1 split · 31 Aug 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.